Stock Groups

Moderna Slumps as FDA OKs Pfizer Booster for Those Aged 12+ -Breaking

by Mike Robinson

[ad_1]

© Reuters

By Dhirendra Tripathi

Investing.com – Moderna Stock fell 8.8% Monday when the Food and Drug Administration expanded use of Covid-19 shots by competitors  Pfizer BioNTech (NASDAQ) (NYSE:), while claiming it is continuing to examine data regarding all vaccines.

Today, the drug regulator ruled that a booster dose of Pfizer BioNTech Covid-19 vaccine is sufficient to offset the possible risks for children aged 12 and over.

A third dose was also approved by the body for immunocompromised kids aged 5 and over. It also shortened the time between the completion of primary vaccination of the Pfizer-BioNTech Covid-19 vaccine and a booster dose to at least five months for all eligible individuals older than 12 years, leaving unchanged the six-month gap for those vaccinated by Moderna’s shot, reports said.

Omicron continues its ravaging in America and elsewhere. The FDA’s decision is timely. The daily infections reported in the U.S. have surpassed 700,000. This is an unprecedented pandemic record, while 1.5 million cases are occurring around the globe every day.

FDA reported that they reviewed safety data from Israel from approximately 6,300 children between 12 and 15 years old who had received booster shots of vaccines at least five months after receiving their first dose.

 

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

[ad_2]